Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects

NCT ID: NCT04704089

Last Updated: 2025-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-18

Study Completion Date

2026-04-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study focuses on the analysis of enamel defects grouping together hypomineralization and hypoplasia. It focuses on 3 very characteristic enamel pathologies that are most often encountered in dental consultations: Molar Incisor Hypomineralization (MIH), dental fluorosis (FD) and amelogenesis imperfecta (AI). The research focuses on the use of a spectrophotometer for measuring tooth colors: the Zfx SpectroShade® (MHT) and its software as a means of early diagnosis of pre-eruptive enamel abnormalities. The main objective of the study is to analyze the color parameters of teeth affected with one of the 3 enamel abnormalities for use of the spectrophotometer as a non-invasive diagnostic tool for enamel defects.

The secondary objective is focused on the biological, structural and physicochemical characterizations of these different enamel pathologies from extracted teeth or enamel biopsies that must be ground to achieve a restoration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methodology:

V1 inclusion visit (D1):

The subjects will be screened during a consultation carried out as part of the treatment in the participating dentistry departments. The inclusion and non-inclusion criteria for participants will be verified and the study will be offered to eligible patients and controls. The research briefing note will be given and the non-objection of the participants (adults and representative (s) of parental authority) will be collected. The investigator will then take the photographs and spectrophotometer shots (at least 2 teeth per participant).

V2 follow-up visit (within 2 months of the inclusion visit (D2 to M2)):

The patients will be reviewed in consultation as part of the treatment for selective grinding for dental restoration or extraction (if the tooth (s) is (are) no longer storable). The teeth or pathological enamel samples will be recovered and centralized at the Laboratory of Oral Molecular Physiopathology.

Biological, structural and physico-chemical analyzes will be carried out from these samples.

In order to ensure follow-up of participants, the principal investigator of each center will maintain a correspondence table including the participant's identity and his research identification number. He will also keep a register of oppositions up to date.

The subject's opposition or participation will be notified in his medical file. A copy of the briefing notes and non-objection forms signed by the dentist will be kept on site with the research documents. Minors who become adults during their participation will benefit from appropriate information and their non-objection will be collected.

Primary endpoint Analysis, using the spectrophotometer, of the numerical values of the color of the teeth in each of the populations studied (Hereditary amelogenesis imperfecta (AIH), dental fluorosis (FD), Hypomineralization Incisors and Molar (MIH) and control).

For each pathology, the values of these parameters will be compared. Secondary endpoints

* Intra-pathology classification according to the severity of each pathology.
* Characterization and biological, structural and physicochemical analysis of these different pathologies from extracted teeth or enamel biopsy to be ground to achieve a restoration.

Sample analysis The teeth samples will be stored at room temperature in the Oral Molecular Physiopathology laboratory in the Research Center.

During the research, biological, structural and physicochemical analyzes will be carried out at the laboratory or in another laboratory in France or abroad. A contract will be established upstream of these analyzes with the partner laboratory.

At the end of the research, samples not destroyed by destructive analysis techniques will be embedded in the resin and stored for 10 years before being destroyed. These samples can be used for additional analyzes (biological, structural and physico-chemical) according to the request of the references for the publication process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amelogenesis Imperfecta Dental Fluoroses Hypomineralization Molar Incisor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

spectrophotometer, and numerical values of tooth color in the populations studied

at the first visit Shooting with Spectrophotometer and at the second visit for all patients except control population: Tooth extraction or restorative treatment Collection of teeth or enamel debris for analysis

spectrophotometer

Intervention Type OTHER

* Calibration of the spectrophotometer (calibration of white and green color on the provided support),
* Placing the patient or witness in the chair,
* Placement of intraoral retractors,
* Photographs of the dental arch in occlusion as well as slightly open mouth to visualize the mandibular incisors,
* If MIH is suspected, occlusal images of the occlusal surfaces of the first molars will be taken with the help of a dental mirror,
* Shooting with the spectrophotometer centered on each of the teeth of interest in the anterior sector with verification of the good quality of the shot according to the axis (validated in green on the camera),
* Backup of images with coded identification number

Biological (protein analysis by western blot or mass spectrometry of matrix proteins), structural (electron microscopy) and physico-chemical analyses

Intervention Type OTHER

* Chemical analysis of enamel mineral.
* Techniques of spectrometry and spectroscopy (Raman and FTIR)
* Atomic Probe Tomography and Protein Mass Spectrometry (ICP-MS).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

spectrophotometer

* Calibration of the spectrophotometer (calibration of white and green color on the provided support),
* Placing the patient or witness in the chair,
* Placement of intraoral retractors,
* Photographs of the dental arch in occlusion as well as slightly open mouth to visualize the mandibular incisors,
* If MIH is suspected, occlusal images of the occlusal surfaces of the first molars will be taken with the help of a dental mirror,
* Shooting with the spectrophotometer centered on each of the teeth of interest in the anterior sector with verification of the good quality of the shot according to the axis (validated in green on the camera),
* Backup of images with coded identification number

Intervention Type OTHER

Biological (protein analysis by western blot or mass spectrometry of matrix proteins), structural (electron microscopy) and physico-chemical analyses

* Chemical analysis of enamel mineral.
* Techniques of spectrometry and spectroscopy (Raman and FTIR)
* Atomic Probe Tomography and Protein Mass Spectrometry (ICP-MS).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age between 8 and 55 years old
2. Carrier of one of the following 3 quantitative pre-eruptive enamel anomalies : AIH, dental fluorosis or MIH
3. Information and collection of the non-opposition of the adult patient or of the representative(s) of parental authority present for the minors.

Criteria for non-inclusion :

1. Pregnant or breastfeeding woman
2. Under guardianship or curators
3. Opposition of the minor patient
4. Presenting pre-eruptive anomalies only on the molars (the spectrophotometer can only take pictures of the anterior dental sector (incisors and canines)).
5. Other types of hypomineralization (post-eruptive, of traumatic or infectious origin, idiopathic).
6. Having undergone radiotherapy or chemotherapy inducing dental and periodontal damage.
7. Having systemic abnormalities (unbalanced diseases), haemochromatosis, porphyria
8. Under medication likely to disturb the coloring of the teeth

For witnesses :


1. Age between 8 and 55 years old
2. Information and collection of the non-opposition of the adult witness or of the representative(s) of parental authority present for the minors.
3. Free of any anomaly of tooth structure, exogenous dyschromia and carious lesions.

Criteria for non-inclusion :

1. Pregnant or breastfeeding woman
2. Under guardianship or curators
3. Opposition of the minor witness
4. Carrier of a quantitative pre-eruptive enamel anomaly
5. Polycarpus (preventing the diagnosis of amyl hypomineralization)
Minimum Eligible Age

8 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'odontologie, Hôpital Pitié-Salpêtrière

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sophia HOUARI, MCU-PH

Role: CONTACT

06 12 16 88 35

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sophia HOUARI, MCU-PH

Role: primary

06 12 16 88 35

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP190001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.